EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 8

Gotu kola Centella asiatica (L.) Urb.

Also called: Centella, Asian pennywort, Indian pennywort, Hydrocotyle asiatica (synonym)

Gotu kola is a creeping, flowering herb eaten as a vegetable and used for centuries in Ayurvedic and Chinese medicine. Products are made from fresh or dried leaves and sold as capsules, tablets, powders, solutions and skin creams.

Category
Botanical
Part used
Leaves and aerial parts (herb)
Strongest evidence
C Limited
Native range
Native from the Caucasus and the tropical and subtropical Old World to eastern Australia and the western Pacific (POWO: "Caucasus, Trop. & Subtrop. Old World to E. Australia and W. Pacific")
Reviewed
2026-10-29

Class 1 Well studied in people. A 2013 systematic review found 8 RCTs of Centella asiatica extracts alone for chronic venous insufficiency (7 of the triterpene fraction TTFCA versus placebo, 1 versus tribenoside). A 2017 review (source [2]) found 5 different RCTs of C. asiatica alone for cognition and mood, for 13 distinct RCTs in all. [8]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Gotu kola does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Gotu kola, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Cognitive functionCA 2017 meta-analysis of randomized trials (five of gotu kola alone) found no significant difference from placebo in any cognitive domain. [2]
Mood measuresCThe 2017 Puttarak meta-analysis found higher alertness scores and lower anger scores one hour after dosing; the authors note limitations in dose, preparation and standardization. [2]
Chronic venous insufficiency of the legsCA 2020 Cochrane review of oral phlebotonics included two placebo-controlled trials of Centella asiatica among 56 trials with usable data; its pooled conclusions (slightly less leg swelling) apply to the drug class. [3]
Overall clinical evidenceCLiverTox states that none of the purported properties have been proven in prospective, controlled trials in humans. [1]

Main constituents: Pentacyclic triterpenoid glycosides (asiaticoside, centelloside, madecassoside) and their aglycones asiatic acid and madecassic acid; extracts contain more than 100 constituents [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • LiverTox describes typical oral amounts as 60 to 120 mg daily of purified extracts, or 600 to 1800 mg daily of dried-leaf capsules or powders (a description of products, not a recommendation). [1]
  • EU traditional-use monograph (cutaneous use only, minor wounds): 0.6 g of herbal substance applied three times daily (1.8 g daily) for no more than 1 week, adults only. [5]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score C
    A: well known causeE: unlikely cause

    LiverTox likelihood score C: probable rare cause of clinically apparent liver injury.

    Details and sources
  • Pregnancy and breastfeeding
    EU monograph: safety during pregnancy and lactation has not been established …

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    1 listed

    Substrates of CYP1A2, CYP2C9, CYP2D6, CYP3A4 and CYP2C19

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    EU (HMPC, traditional use, 30 March 2022): cutaneous use only to aid healing of minor wounds …

    Details and sources
  • Liver: LiverTox likelihood score C (probable rare cause of clinically apparent liver injury). Published cases had onset 3 to 8 weeks after starting, hepatocellular injury, and full recovery within 1 to 2 months of stopping. [1]
  • In small trials, extracts were well tolerated, with mild, transient effects such as headache, dizziness, bloating, diarrhea and nausea; rare allergic reactions, mainly with topical use. [1]
  • Contact dermatitis has been reported. [4]
  • EU monograph: use during pregnancy and lactation is not recommended because safety has not been established; contraindicated with hypersensitivity to other plants of the Apiaceae (Umbelliferae) family. [5]
Interactions

Interactions

Known interactions of Gotu kola
WithWhat happens
Drugs metabolized by CYP1A2, CYP2C9, CYP2D6, CYP3A4 or CYP2C19Gotu kola inhibited these enzymes in laboratory studies and may affect levels of drugs they metabolize; clinical relevance has not been determined. [4]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • EU monograph material complies with the European Pharmacopoeia monograph for Centella (ref. 1498). [5]
  • In the published liver-injury cases, contamination or other hepatotoxins in the commercial products was not ruled out. [1]
Regulation

Regulatory status

  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
  • EU: the HMPC adopted a European Union herbal monograph (revision 1, 30 March 2022) for traditional cutaneous use to aid healing of minor wounds; no oral use is covered. [5]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Asiaticoside, centelloside and madecassoside, with their aglycones asiatic acid and madecassic acid Pentacyclic triterpenoid glycosides (triterpenoids) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming gotu kola (Centella asiatica) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of gotu kola (Centella asiatica) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
  • The EU herbal monograph states that adequate tests on genotoxicity and carcinogenicity have not been performed. [P6]

Liver (NIH LiverTox)

  • LiverTox likelihood score C: probable rare cause of clinically apparent liver injury. Cases (including three Argentinian women using it for weight loss) had onset at 3 to 8 weeks, hepatocellular injury and full recovery 1 to 2 months after stopping (chapter updated 2024-04-24). [P1]

Interactions with medicines

  • Substrates of CYP1A2, CYP2C9, CYP2D6, CYP3A4 and CYP2C19: Inhibited these enzymes in vitro; may affect concentrations of drugs they metabolize. Clinical relevance has not been determined. [P4]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P5]
  • Compliance with the European Pharmacopoeia monograph for Centella (ref. 1498) — The EU herbal monograph specifies that the herbal substance complies with this Ph. Eur. monograph. [P6]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P7]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU (HMPC, traditional use, 30 March 2022): cutaneous use only to aid healing of minor wounds; 0.6 g comminuted herb as a warm infusion on a dressing, or 0.6 g powder, applied 3 times daily (daily dose 1.8 g); not for more than 1 week; not recommended under 18 years. [P6]

Pregnancy and breastfeeding

  • EU monograph: safety during pregnancy and lactation has not been established; in the absence of sufficient data, use during pregnancy and lactation is not recommended. [P6]

Sources for this profile

  1. NIH LiverTox (NIDDK). Centella (Gotu Kola) (Last Update: 2024-04-24), 2024-04-24. ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  4. Memorial Sloan Kettering Cancer Center. About Herbs: Gotu Kola (last updated February 23, 2022), 2022-02-23. mskcc.org
  5. eCFR. 21 CFR 111.75 (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  6. EMA/HMPC. European Union herbal monograph on Centella asiatica (L.) Urb., herba, revision 1 (EMA/HMPC/489142/2020, 30 March 2022), 2022-03-30. ema.europa.eu
  7. GBIF species API: IUCN Red List category for Centella asiatica (L.) Urb., 2026-10-29. api.gbif.org
Sources

Sources

  1. NIH LiverTox (NIDDK). Centella (Gotu Kola) (Last Update: 2024-04-24), 2024-04-24. ncbi.nlm.nih.gov
  2. Puttarak P, et al. Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: a systematic review and meta-analysis. Sci Rep 2017;7:10646 (PMID 28878245), 2017-09-06. pubmed.ncbi.nlm.nih.gov
  3. Martinez-Zapata MJ, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2020;11:CD003229 (PMID 33141449), 2020-11-03. pubmed.ncbi.nlm.nih.gov
  4. Memorial Sloan Kettering Cancer Center. About Herbs: Gotu Kola (last updated February 23, 2022), 2022-02-23. mskcc.org
  5. EMA/HMPC. European Union herbal monograph on Centella asiatica (L.) Urb., herba, revision 1 (EMA/HMPC/489142/2020, 30 March 2022), 2022-03-30. ema.europa.eu
  6. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Centella asiatica (L.) Urb. (accessed 2026-10-29); synonym Hydrocotyle asiatica L. per WCVP (GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, 2026-06-04). powo.science.kew.org
  7. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  8. Chong NJ, et al. A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency. Evid Based Complement Alternat Med 2013;2013:627182 (PMID 23533507), 2013-02-21. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.